Cargando…

Invasive Surgery Impairs the Regulatory Function of Human CD56(bright) Natural Killer Cells in Response to Staphylococcus aureus. Suppression of Interferon-γ Synthesis

Major surgery increases the risk for infectious complications due to the development of immunosuppression. CD56(bright) NK cells play a key role in the defense against bacterial infections through the release of Interferon (IFN) γ upon stimulation with monocyte-derived Interleukin (IL) 12. We invest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reinhardt, Renate, Pohlmann, Stephanie, Kleinertz, Holger, Hepner-Schefczyk, Monika, Paul, Andreas, Flohé, Stefanie B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474941/ https://www.ncbi.nlm.nih.gov/pubmed/26090673 http://dx.doi.org/10.1371/journal.pone.0130155

Ejemplares similares

Circulating growth/differentiation factor 15 is associated with human CD56(bright) natural killer cell dysfunction and nosocomial infection in severe systemic inflammation
por: Kleinertz, Holger, et al.
Publicado: (2019)

An Inverse Relationship Between c-Kit/CD117 and mTOR Confers NK Cell Dysregulation Late After Severe Injury
por: Bösken, Björn, et al.
Publicado: (2020)

Human mesenchymal stromal/stem cells acquire immunostimulatory capacity upon cross-talk with natural killer cells and might improve the NK cell function of immunocompromised patients
por: Cui, Rongtao, et al.
Publicado: (2016)

Staphylococcus aureus β-Hemolysin Up-Regulates the Expression of IFN-γ by Human CD56(bright) NK Cells
por: Guan, Zhangchun, et al.
Publicado: (2021)

Distinct Signatures in the Receptor Repertoire Discriminate CD56bright and CD56dim Natural Killer Cells
por: Schwane, Vera, et al.
Publicado: (2020)

Evaluation of CD56(dim) and CD56(bright) natural killer cells in peripheral blood of women with IVF failures
por: Mardanian, Farahnaz, et al.
Publicado: (2015)

Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations
por: Melsen, Janine E., et al.
Publicado: (2016)

CD56(bright)CD16(-) natural killer cells as an important regulatory mechanism in chronic graft-versus-host disease
por: Lauener, Madeline P., et al.
Publicado: (2022)

Human Natural Killer Cell Maturation Defect Supports In Vivo CD56(bright) to CD56(dim) Lineage Development
por: Domaica, Carolina Inés, et al.
Publicado: (2012)

CD56(bright) natural killer cells and response to daclizumab HYP in relapsing-remitting MS
por: Elkins, J., et al.
Publicado: (2015)

Intratumoral CD56(bright) natural killer cells are associated with improved survival in bladder cancer
por: Mukherjee, Neelam, et al.
Publicado: (2018)

CD56(bright) natural killer cells preferentially kill proliferating CD4(+) T cells
por: Lee, Mercede, et al.
Publicado: (2023)

Hobit expression by a subset of human liver-resident CD56(bright) Natural Killer cells
por: Lunemann, Sebastian, et al.
Publicado: (2017)

CD56bright Natural Killer Cells: A Possible Biomarker of Different Treatments in Multiple Sclerosis
por: Laroni, Alice, et al.
Publicado: (2020)

Interleukin (IL)-23 Stimulates IFN-γ Secretion by CD56(bright) Natural Killer Cells and Enhances IL-18-Driven Dendritic Cells Activation
por: Ziblat, Andrea, et al.
Publicado: (2018)

Cytotoxicity of Human Hepatic Intrasinusoidal CD56(bright) Natural Killer Cells against Hepatocellular Carcinoma Cells
por: Hwang, Shin, et al.
Publicado: (2019)

Interaction with Mesenchymal Stem Cells Provokes Natural Killer Cells for Enhanced IL-12/IL-18-Induced Interferon-Gamma Secretion
por: Thomas, Heike, et al.
Publicado: (2014)

Natural killer cells 56(bright)16(−) have higher counts in the umbilical cord blood than in the adult peripheral blood
por: de Molla, Vinicius Campos, et al.
Publicado: (2023)

The phenotype of CD3–CD56(bright) and CD3–CD56(dim) natural killer cells in systemic lupus erythematosus patients and its relation to disease activity
por: Soelistyoningsih, Dwi, et al.
Publicado: (2022)

CD3(bright)CD56(+) T cells associate with pegylated interferon-alpha treatment nonresponse in chronic hepatitis B patients
por: Guo, Chuang, et al.
Publicado: (2016)

Role of Uterine Natural Killer Cells and Interferon γ in Placental Development
por: Redline, Raymond W.
Publicado: (2000)

Human Placental Cytotrophoblasts Attract Monocytes and Cd56(bright) Natural Killer Cells via the Actions of Monocyte Inflammatory Protein 1α
por: Drake, Penelope M., et al.
Publicado: (2001)

Lysostaphin-Coated Titan-Implants Preventing Localized Osteitis by Staphylococcus aureus in a Mouse Model
por: Windolf, Ceylan D., et al.
Publicado: (2014)

CD300c is uniquely expressed on CD56(bright) Natural Killer Cells and differs from CD300a upon ligand recognition
por: Dimitrova, Milena, et al.
Publicado: (2016)

The involvement of circulating CD69(+) CD56(bright) natural killer cells in weight loss before bariatric surgery: A retrospective cohort study
por: Chikuie, Emi, et al.
Publicado: (2023)

Interferon Regulatory Factor (Irf)-1 and Irf-2 Regulate Interferon γ–Dependent Cyclooxygenase 2 Expression
por: Blanco, Jorge C. G., et al.
Publicado: (2000)

The Transcription Factor Promyelocytic Leukemia Zinc Finger Protein Is Associated With Expression of Liver‐Homing Receptors on Human Blood CD56(bright) Natural Killer Cells
por: Hess, Leonard U., et al.
Publicado: (2020)

Reinforced Cytotoxicity of Lymphokine‐activated Killer Cells toward Glioma Cells by Transfection of the Killer Cells with the γ‐Interferon Gene
por: Mizuno, Masaaki, et al.
Publicado: (1995)

Interferon-γ-Mediated Natural Killer Cell Activation by an Aqueous Panax ginseng Extract
por: Takeda, Kazuyoshi, et al.
Publicado: (2015)

NK cells CD56(bright) and CD56(dim) subset cytokine loss and exhaustion is associated with impaired survival in myeloma
por: Seymour, Frances, et al.
Publicado: (2022)

Natural Killer Cell Cytokine Response to M. bovis BCG Is Associated with Inhibited Proliferation, Increased Apoptosis and Ultimate Depletion of NKp44(+)CD56(bright) Cells
por: Portevin, Damien, et al.
Publicado: (2013)

Impairment of Natural Killer Cytotoxic Activity and Interferon γ Production in Ccaat/Enhancer Binding Protein γ–Deficient Mice
por: Kaisho, Tsuneyasu, et al.
Publicado: (1999)

CD56(bright) natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-versus-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results
por: Kariminia, Amina, et al.
Publicado: (2017)

Toxin-mediated gene regulatory mechanism in Staphylococcus aureus
por: Joo, Hwang-Soo, et al.
Publicado: (2016)

The Increased Ratio of Blood CD56(bright) NK to CD56(dim) NK Is a Distinguishing Feature of Primary Sjögren's Syndrome
por: Ming, Bingxia, et al.
Publicado: (2020)

Ageing is associated with a decline in peripheral blood CD56(bright )NK cells
por: Chidrawar, Shivani M, et al.
Publicado: (2006)

Circulating CD56(bright) NK cells inversely correlate with survival of melanoma patients
por: de Jonge, Kaat, et al.
Publicado: (2019)

Increased level and interferon-γ production of circulating natural killer cells in patients with scrub typhus
por: Kang, Seung-Ji, et al.
Publicado: (2017)

CD56(dim) CD16(−) Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α
por: Vujanovic, Lazar, et al.
Publicado: (2019)

Impact of polysialylated CD56 on natural killer cell cytotoxicity
por: Moebius, Jeannette M, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_aae4tlvv3sd8ha6nj3iubd0i1e